T2 Biosystems Inc Kapitalrendite
Was ist das Kapitalrendite von T2 Biosystems Inc?
Kapitalrendite von T2 Biosystems Inc ist 212.27%
Was ist die Definition von Kapitalrendite?
Die Eigenkapitalrendite ist ein Maß für die Rentabilität eines Unternehmens im Verhältnis zum Buchwert des Eigenkapitals. Sie wird berechnet, indem das Nettoergebnis des Geschäftsjahres durch das gesamte Eigenkapital geteilt wird.
The return on equity (ROE) ROE is a measure of how well a company uses investments to generate earnings growth. ROE is used for comparing the performance of companies in the same industry. It indicated the management's ability to generate income from the equity available to it. ROEs of 15-20% are generally considered good. ROEs are also a factor in stock valuation, in association with other financial ratios. In general, stock prices are influenced by earnings per share (EPS), so that stock of a company with a 20% ROE will generally cost twice as much as one with a 10% ROE.
Kapitalrendite von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu T2 Biosystems Inc
Was macht T2 Biosystems Inc?
t2 biosystems is developing innovative diagnostic products to improve patient health. with two fda-cleared products targeting sepsis – the cause of one out of two hospital deaths - and a range of additional products in development, t2 biosystems is an emerging leader in the field of in vitro diagnostics. our initial development efforts target sepsis, hemostasis, bacteria and lyme disease, which are areas of significant unmet medical need. the company is utilizing its proprietary t2 magnetic resonance platform, or t2mr®, to develop a broad set of applications aimed at lowering mortality rates, improving patient outcomes and reducing the cost of healthcare by helping medical professionals make targeted treatment decisions earlier. at t2 biosystems, we know that our passion to advance the medical diagnostic landscape relies on our ability to attract and retain the very best people in the world – and to encourage them to flourish. we invite you to apply for one of our open positions at www
Unternehmen mit kapitalrendite ähnlich T2 Biosystems Inc
- Waters hat Kapitalrendite von 204.84%
- Cardinal Resources hat Kapitalrendite von 206.23%
- Sakthi Sugars hat Kapitalrendite von 206.46%
- Flexion Therapeutics Inc hat Kapitalrendite von 207.60%
- Vapotherm Inc hat Kapitalrendite von 209.65%
- Central African Gold hat Kapitalrendite von 209.77%
- T2 Biosystems Inc hat Kapitalrendite von 212.27%
- Luminar Technologies Inc hat Kapitalrendite von 212.98%
- MV Oil Trust hat Kapitalrendite von 213.34%
- K. H hat Kapitalrendite von 213.68%
- Hornby Bay Mineral Exploration hat Kapitalrendite von 214.23%
- Carmat SA hat Kapitalrendite von 215.64%
- Clancy hat Kapitalrendite von 215.66%